Tissue perfusion pressure as a physiologic indicator of renal failure risk after heart transplantation.

IF 6.7 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Chen Chia Wang, Walter Navid, Christian Eidson, Awab Ahmad, Mark Petrovic, Nikith Kurella, Kevin McGann, Aaron M Williams, John Trahanas, Swaroop Bommareddi, Tarek Absi, Eric Quintana, Aniket S Rali, Kelly Schlendorf, Matthew Bacchetta, Ashish Shah, Brian Lima
{"title":"Tissue perfusion pressure as a physiologic indicator of renal failure risk after heart transplantation.","authors":"Chen Chia Wang, Walter Navid, Christian Eidson, Awab Ahmad, Mark Petrovic, Nikith Kurella, Kevin McGann, Aaron M Williams, John Trahanas, Swaroop Bommareddi, Tarek Absi, Eric Quintana, Aniket S Rali, Kelly Schlendorf, Matthew Bacchetta, Ashish Shah, Brian Lima","doi":"10.1016/j.healun.2026.07.025","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mean arterial pressure (MAP) guides hemodynamic management following heart transplantation, yet renal failure remains common. Tissue perfusion pressure (TPP), defined as MAP minus critical closing pressure, predicts acute kidney injury in non-transplant cardiac surgery. We hypothesized that postoperative TPP predicts continuous renal replacement (CRRT) requirement after heart transplantation.</p><p><strong>Methods: </strong>We analyzed all adult heart transplants at a single institution (01/2020-06/2025) and excluded multiorgan transplants, congenital heart disease, and patients requiring post-transplant extracorporeal membrane oxygenation support. Hourly TPP, MAP, and organ perfusion pressure (OPP; MAP - central venous pressure) were analyzed over 72 h. Patients were stratified by post-transplant CRRT use. Predictive performance was compared using net reclassification improvement (NRI) across sequential 24-hour epochs.</p><p><strong>Results: </strong>Of the 269 patients included, 47 (17.5%) required CRRT. Those needing CRRT more likely had circulatory death donors (55.3% vs 38.3%, p=0.035) using direct procurement and perfusion (14.9% vs 6.3%, p=0.037). Pre-transplant creatinine was greater in the CRRT group (1.5mg/dL vs 1.2, p=0.002). In the CRRT group, the median and mean TPP, OPP, and MAP within the first 72 h were all lower (p < 0.01). Mean TPP demonstrated better prediction of CRRT compared to OPP (NRI 0.49, 95% CI 0.23-0.76, p<0.001) and MAP (NRI 0.39, 95% CI 0.11-0.68, p=0.007) within 24 h post-transplant. After 24 h, the predictive powers of median TPP, OPP, and MAP were similar.</p><p><strong>Conclusions: </strong>Early postoperative TPP independently predicted the need for CRRT after heart transplantation and demonstrated superior risk reclassification compared with conventional pressure-based hemodynamic metrics.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.7000,"publicationDate":"2026-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Heart and Lung Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.healun.2026.07.025","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Mean arterial pressure (MAP) guides hemodynamic management following heart transplantation, yet renal failure remains common. Tissue perfusion pressure (TPP), defined as MAP minus critical closing pressure, predicts acute kidney injury in non-transplant cardiac surgery. We hypothesized that postoperative TPP predicts continuous renal replacement (CRRT) requirement after heart transplantation.

Methods: We analyzed all adult heart transplants at a single institution (01/2020-06/2025) and excluded multiorgan transplants, congenital heart disease, and patients requiring post-transplant extracorporeal membrane oxygenation support. Hourly TPP, MAP, and organ perfusion pressure (OPP; MAP - central venous pressure) were analyzed over 72 h. Patients were stratified by post-transplant CRRT use. Predictive performance was compared using net reclassification improvement (NRI) across sequential 24-hour epochs.

Results: Of the 269 patients included, 47 (17.5%) required CRRT. Those needing CRRT more likely had circulatory death donors (55.3% vs 38.3%, p=0.035) using direct procurement and perfusion (14.9% vs 6.3%, p=0.037). Pre-transplant creatinine was greater in the CRRT group (1.5mg/dL vs 1.2, p=0.002). In the CRRT group, the median and mean TPP, OPP, and MAP within the first 72 h were all lower (p < 0.01). Mean TPP demonstrated better prediction of CRRT compared to OPP (NRI 0.49, 95% CI 0.23-0.76, p<0.001) and MAP (NRI 0.39, 95% CI 0.11-0.68, p=0.007) within 24 h post-transplant. After 24 h, the predictive powers of median TPP, OPP, and MAP were similar.

Conclusions: Early postoperative TPP independently predicted the need for CRRT after heart transplantation and demonstrated superior risk reclassification compared with conventional pressure-based hemodynamic metrics.

组织灌注压作为心脏移植后肾功能衰竭风险的生理指标。
背景:平均动脉压(MAP)指导心脏移植后的血流动力学管理,但肾功能衰竭仍然很常见。组织灌注压(TPP),定义为MAP减去临界闭合压,预测非移植心脏手术急性肾损伤。我们假设术后TPP预测心脏移植后持续肾替代(CRRT)需求。方法:我们分析了同一机构(2020年1月1日- 2025年6月)的所有成人心脏移植病例,排除了多器官移植、先天性心脏病和需要移植后体外膜氧合支持的患者。在72小时内分析小时TPP、MAP和器官灌注压(OPP; MAP -中心静脉压)。根据移植后CRRT的使用对患者进行分层。预测性能采用连续24小时的净重分类改进(NRI)进行比较。结果:纳入的269例患者中,47例(17.5%)需要CRRT。需要CRRT的患者更可能是使用直接采购和灌注的循环性死亡供者(55.3% vs 38.3%, p=0.035) (14.9% vs 6.3%, p=0.037)。移植前肌酐水平在CRRT组较高(1.5mg/dL vs 1.2, p=0.002)。CRRT组前72小时内TPP、OPP、MAP的中位数和平均值均降低(p < 0.01)。与OPP相比,平均TPP能更好地预测CRRT (NRI 0.49, 95% CI 0.23-0.76)。结论:术后早期TPP能独立预测心脏移植后CRRT的需要,与传统的基于压力的血流动力学指标相比,其风险重分类具有优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.10
自引率
6.70%
发文量
1667
审稿时长
69 days
期刊介绍: The Journal of Heart and Lung Transplantation, the official publication of the International Society for Heart and Lung Transplantation, brings readers essential scholarly and timely information in the field of cardio-pulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书